Back to Journals » OncoTargets and Therapy » Volume 11

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway

Total article views   HTML views PDF downloads Totals
8,438 Dovepress* 7,315+ 707 8,022
PubMed Central* 1,123 225 1,348
Totals 8,438 932 9,370
*Since 25 September 2018

View citations on PubMed Central and Google Scholar